Devicemaker Transfer Technology racked up a 12-item Form 483 covering a multitude of quality management issues following an FDA inspection of its Huntington Beach, California facility.

Medegen Medical Products was cited for validation lapses and failure to control nonconforming product following an FDA inspection of its Gallaway, Tennessee plant.

Labeling failures and validation lapses were among the quality system lapses uncovered during an FDA inspection of CDB Corp.’s Leland, North Carolina facility.